Additional information
| Active substance | Silodosin |
|---|---|
| Water Retention | Minimal to none |
| Hepatotoxicity | Low |
| Lab Test | Not specific |
| Also known as | KMD-3213 |
| Blood pressure | May cause a decrease in blood pressure |
| Trade name | Rapaflo, Silodyx |
| Storage conditions | Store at room temperature away from moisture and heat |
| Chemical name | 1-(3-Hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide |
| Formula | C25H32F3N3O4 |
| Substance class | Alpha-1 adrenergic receptor antagonist |
| Main action | Reduces smooth muscle contraction in the prostate and urethra |
| Half-life | Approximately 13 hours |
| Dosage (medical) | Typically 8 mg once daily |
| Dosage (sports) | Not applicable |
| Effects | Improves urinary flow and symptoms associated with benign prostatic hyperplasia (BPH) |
| Side effects | Dizziness, orthostatic hypotension, retrograde ejaculation, headache, diarrhea |
| Use in sports | None |
| Manufacturer | Recordati |
| Packing | 30 tabs (4mg/tab) |
LACIPIL 4 mg Glaxosmithkline
Clen 40 SINGANI PHARMA
Norvacs 5 mg Pfizer
Balkan Pharma Danabol 50 mg 60 Tabletten
Thyromazol 5 mg Abdi Ibragim
Bvs Labs Dianabol 10mg 100 Tabletten
Spiriva HandiHaler 18mg Boehringer Ingelheim
Prograf 5mg Astellas Pharma
Seretide Disckus (Advair) 250 mcg Glaxosmithkline
Champix Starter Pack Pfizer
Rovamycine 3.000.000 iu Eczacibasi
Prograf 1mg Astellas Pharma 

Reviews
There are no reviews yet.